- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.09 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.3: 9 residues within 4Å:- Chain A: S.588, S.591, A.592, N.595, Q.697
- Chain B: H.69, E.233, Y.234, R.311
4 PLIP interactions:4 interactions with chain B- Water bridges: B:E.233, B:E.233, B:H.69
- Hydrogen bonds: B:E.233, B:R.311, B:R.311
NAG-NAG-BMA-MAN.17: 9 residues within 4Å:- Chain A: H.69, E.233, Y.234, R.311
- Chain B: S.588, S.591, A.592, N.595, Q.697
4 PLIP interactions:4 interactions with chain A- Water bridges: A:E.233, A:E.233, A:H.69
- Hydrogen bonds: A:E.233, A:R.311, A:R.311
- 8 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.4: 4 residues within 4Å:- Chain A: N.78, T.80, H.81, T.306
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:T.306
- Hydrogen bonds: A:T.80
NAG.5: 4 residues within 4Å:- Chain A: Y.84, E.94, I.95, N.97
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:Y.84, A:E.94, A:E.94, A:N.97
NAG.6: 2 residues within 4Å:- Chain A: N.152, S.154
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:S.154
NAG.7: 4 residues within 4Å:- Chain A: W.203, N.416, F.522, Y.523
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:W.203, A:Y.523
- Hydrogen bonds: A:W.203, A:F.522
- Water bridges: A:N.416
NAG.18: 4 residues within 4Å:- Chain B: N.78, T.80, H.81, T.306
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:T.306
- Hydrogen bonds: B:T.80
NAG.19: 4 residues within 4Å:- Chain B: Y.84, E.94, I.95, N.97
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:Y.84, B:E.94, B:E.94, B:N.97
NAG.20: 2 residues within 4Å:- Chain B: N.152, S.154
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:S.154
NAG.21: 4 residues within 4Å:- Chain B: W.203, N.416, F.522, Y.523
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:W.203, B:Y.523
- Hydrogen bonds: B:W.203, B:F.522
- Water bridges: B:N.416
- 4 x ZN: ZINC ION(Non-covalent)
ZN.8: 5 residues within 4Å:- Chain A: D.344, E.382, H.510
- Ligands: ZN.9, G8W.13
5 PLIP interactions:4 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:D.344, A:E.382, A:E.382, A:H.510, H2O.5
ZN.9: 6 residues within 4Å:- Chain A: H.334, D.344, E.381, E.382, D.410
- Ligands: ZN.8
5 PLIP interactions:4 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:H.334, A:D.344, A:D.410, A:D.410, H2O.5
ZN.22: 5 residues within 4Å:- Chain B: D.344, E.382, H.510
- Ligands: ZN.23, G8W.27
5 PLIP interactions:4 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:D.344, B:E.382, B:E.382, B:H.510, H2O.20
ZN.23: 6 residues within 4Å:- Chain B: H.334, D.344, E.381, E.382, D.410
- Ligands: ZN.22
5 PLIP interactions:4 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:H.334, B:D.344, B:D.410, B:D.410, H2O.20
- 2 x CA: CALCIUM ION(Non-covalent)
CA.10: 4 residues within 4Å:- Chain A: T.226, Y.229, E.390, E.393
5 PLIP interactions:4 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:T.226, A:E.390, A:E.390, A:E.393, H2O.3
CA.24: 4 residues within 4Å:- Chain B: T.226, Y.229, E.390, E.393
5 PLIP interactions:4 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:T.226, B:E.390, B:E.390, B:E.393, H2O.18
- 4 x CL: CHLORIDE ION(Non-functional Binders)
CL.11: 4 residues within 4Å:- Chain A: N.408, D.410, R.491, R.493
Ligand excluded by PLIPCL.14: 4 residues within 4Å:- Chain A: Y.191, G.505, Y.509
- Ligands: G8W.13
Ligand excluded by PLIPCL.25: 4 residues within 4Å:- Chain B: N.408, D.410, R.491, R.493
Ligand excluded by PLIPCL.28: 4 residues within 4Å:- Chain B: Y.191, G.505, Y.509
- Ligands: G8W.27
Ligand excluded by PLIP- 2 x TAM: TRIS(HYDROXYETHYL)AMINOMETHANE(Non-covalent)
TAM.12: 3 residues within 4Å:- Chain A: S.458, R.468, W.498
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:W.498
- Hydrogen bonds: A:S.458
TAM.26: 3 residues within 4Å:- Chain B: S.458, R.468, W.498
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:W.498
- Hydrogen bonds: B:S.458
- 2 x G8W: (2~{S})-2-[[(2~{S})-6-[(6-fluoranylpyridin-3-yl)amino]-1-oxidanyl-1,6-bis(oxidanylidene)hexan-2-yl]carbamoylamino]pentanedioic acid(Non-covalent)
G8W.13: 22 residues within 4Å:- Chain A: K.164, F.166, R.167, N.214, D.344, E.381, E.382, G.384, L.385, G.475, N.476, R.491, R.493, S.504, G.505, Y.509, H.510, N.655, K.656, Y.657
- Ligands: ZN.8, CL.14
18 PLIP interactions:18 interactions with chain A- Hydrophobic interactions: A:Y.509
- Hydrogen bonds: A:N.214, A:G.475, A:G.475, A:N.476, A:G.505, A:Y.509
- Water bridges: A:N.214, A:D.344, A:R.420, A:R.491, A:K.656
- Salt bridges: A:R.167, A:R.491, A:R.493, A:H.510, A:K.656
- pi-Stacking: A:Y.657
G8W.27: 22 residues within 4Å:- Chain B: K.164, F.166, R.167, N.214, D.344, E.381, E.382, G.384, L.385, G.475, N.476, R.491, R.493, S.504, G.505, Y.509, H.510, N.655, K.656, Y.657
- Ligands: ZN.22, CL.28
18 PLIP interactions:18 interactions with chain B- Hydrophobic interactions: B:Y.509
- Hydrogen bonds: B:N.214, B:G.475, B:G.475, B:N.476, B:G.505, B:Y.509
- Water bridges: B:N.214, B:D.344, B:R.420, B:R.491, B:K.656
- Salt bridges: B:R.167, B:R.491, B:R.493, B:H.510, B:K.656
- pi-Stacking: B:Y.657
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nakajima, R. et al., 2-Aminoadipic Acid-C(O)-Glutamate Based Prostate-Specific Membrane Antigen Ligands for Potential Use as Theranostics. ACS Med Chem Lett (2018)
- Release Date
- 2018-12-05
- Peptides
- Glutamate carboxypeptidase 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.09 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 8 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x ZN: ZINC ION(Non-covalent)
- 2 x CA: CALCIUM ION(Non-covalent)
- 4 x CL: CHLORIDE ION(Non-functional Binders)
- 2 x TAM: TRIS(HYDROXYETHYL)AMINOMETHANE(Non-covalent)
- 2 x G8W: (2~{S})-2-[[(2~{S})-6-[(6-fluoranylpyridin-3-yl)amino]-1-oxidanyl-1,6-bis(oxidanylidene)hexan-2-yl]carbamoylamino]pentanedioic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nakajima, R. et al., 2-Aminoadipic Acid-C(O)-Glutamate Based Prostate-Specific Membrane Antigen Ligands for Potential Use as Theranostics. ACS Med Chem Lett (2018)
- Release Date
- 2018-12-05
- Peptides
- Glutamate carboxypeptidase 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A